Claims for Patent: 5,741,663

Summary for Patent: 5,741,663

Title:	Selective additive and media for Pseudomonas fluorescens
Abstract:	The present invention provides methods and compositions for the specific detection of Pseudomonas fluorescens and for the selective growth of this bacterium. In a preferred embodiment, selective growth of P. fluorescens is effected by the combination of Irgasan, carbenicillin and nitrofurantoin in a bacteriological medium comprising suitable nutrients for its growth. Also provided is a fast, reliable and economical method for the assessment of microbial quality of a fresh animal product, such as poultry, beef, fish, shellfish, milk or the like, using media selective for the growth of P. fluorescens and detection methods for microbial growth in the selective media.
Inventor(s):	Russell; Scott Marshall (Athens, GA)
Assignee:	University of Georgia Research Foundation, Inc. (Athens, GA)
Application Number:	08/632,929
Patent Claims:	1. A bacteriological growth medium selective for Pseudomonas fluorescens, said selective medium comprising a nutrient component capable of supporting growth of P. fluorescens and a compound of the formula ##STR3## where R is a halogen and R.sub.1 is H or Cl, at a concentration of between about 1 and 50 .mu.g/mL, carbenicillin at a concentration of between 5 and 800 .mu.g/ml and nitrofurantoin at a concentration of between about 1 and about 200 .mu.g/mL. 2. The medium of claim 1 comprising Irgasan at a concentration of about 25 to about 30 .mu.g/mL, carbenicillin at a concentration of about 120 to about 130 .mu.g/mL and nitrofurantoin at a concentration of about 3 to about 20 .mu.g/mL. 3. The medium of claim 2 comprising a compound of the formula Irgasan at a concentration of Irgasan of 25 .mu.g/mL, carbenicillin at a concentration of 120 .mu.g/mL and nitrofurantoin at a concentration of 4 .mu.g/mL. 4. A method for the detection of Pseudomonas fluorescens in or on a fresh animal product, said method comprising the steps of: a) washing a sample of said fresh animal product with a suitable sterile diluent to produce a product wash fluid; b) inoculating the bacteriological growth medium of claim 2 with an aliquot of the wash fluid of step (a), said nutrient component of said bacteriological growth being suitable for impedance measurements, to produce inoculated selective growth medium; c) incubating said inoculated selective growth medium at a temperature between about 10.degree. and 30.degree. C.; d) detecting microbial growth by measuring decrease in impedance, increase in capacitance or increase in turbidity of the incubated growth medium of step (c) in comparison to uninoculated medium at intervals from about 1 to about 10 hours or until a detectable change in impedance, capacitance or turbidity in said incubated, inoculated, selective growth medium; whereby P. fluorescens is detected in or on said fresh animal product when the impedance, capacitance or turbidity of the incubated, inoculated selective growth medium is detectably increased as compared to the capacitance or turbidity of the uninoculated growth medium or delectably decreased as compared to the impedance of the uninoculated growth medium. 5. The method of claim 4 wherein the nutrient component of said bacteriological medium comprises Brain Hear Infusion Broth. 6. The method of claim 4 wherein said fresh animal product is poultry. 7. The method of claim 6 wherein said fresh animal product is a chicken carcass or a part thereof. 8. The method of claim 4 wherein said fresh animal product is selected from the group consisting of beef, pork, veal, lamb, fish, shellfish, and dairy products. 9. A Pseudomonas fluorescens selective additive comprising Irgasan, carbonic film and nitrofurantoin in a ratio, by weight, of 25:120:4. 10. A method for the selection of Pseudomonas fluorescens from a sample comprising a mixture of bacteria, said method comprising the step of culturing a portion of said sample in the bacteriological growth medium of claim 1. 11. The method of claim 10, wherein the step of culturing is carried out in a bacteriological medium comprising Irgasan at a concentration from about 25 to about 30 .mu.g/ml, carbenicillin at concentration from about 120 to about 130 .mu.g/ml, and nitrofurantoin at a concentration from about 3 to about 20 .mu.g/ml. 12. The method of claim 11 wherein the nutrient component of said bacteriological medium is Brain Heart Infusion Broth. 13. The method of claim 11 wherein the nutrient component of said bacteriological medium is Brain Heart Infusion Agar.

Details for Patent 5,741,663

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23